Drug Profile
MRX 1024
Alternative Names: MRX-1024Latest Information Update: 25 Sep 2015
Price :
$50
*
At a glance
- Originator Molecular Therapeutics
- Developer Charles River Laboratories
- Class Small molecules; Sulfur amino acids
- Mechanism of Action Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Sensorineural hearing loss; Stomatitis